People Search
Phones, Emails, Addresses, Background check, Web references
All public info
Like other search engines (Google or Bing) Radaris collects information from public sources.
Licensed for Gliadel ® Wafer in Japan April 6, 2009 Nobelpharma Co., Ltd. Nobelpharma Co., Ltd. (Nobelpharma, Headquarters: Tokyo, President: Jin Shiomura) has entered a licensing ...
... 6Usefulness of therapy of Wilson's disease with zinc acetate: Correlation with efficacy and pharmacokinetics of copper and zinc ◯Masataka SHIMOKAWA 1, Toshihide ENDO 1, Jin SHIOMURA 1 ...
... intravenous injection First application for neonatal seizures in the world December 15, 2008 Nobelpharma Co., Ltd. Nobelpharma Co., Ltd. (headquarters in Chuo-ku, Tokyo; Jin Shiomura ...
... Haruo Naito, “Eisai”) announced today that Eisai entered into a license agreement with Nobelpharma Co., Ltd. (Headquarters: Tokyo, Representative Director & CEO: Jin Shiomura ...
Jin Shiomura, Nobelpharma Co., Ltd. Yoshiaki Obata, Egon Zehnder International Toshihiko Okazaki Shinichi Yonehara, Simon Murray & Co. (Japan) Nikolai N. Borisov, Japan Atomic ...
Licensed for Gliadel ® Wafer in Japan April 6, 2009 Nobelpharma Co., Ltd. Nobelpharma Co., Ltd. (Nobelpharma, Headquarters: Tokyo, President: Jin Shiomura) has entered a ...
... of therapy of Wilson's disease with zinc acetate: Correlation with efficacy and pharmacokinetics of copper and zinc ◯Masataka SHIMOKAWA 1, Toshihide ENDO 1, Jin SHIOMURA 1 1 ...
... First application for neonatal seizures in the world December 15, 2008 Nobelpharma Co., Ltd. Nobelpharma Co., Ltd. (headquarters in Chuo-ku, Tokyo; Jin Shiomura ...
Linkedin